Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

October 29, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

October 12, 2018

Conditions
Scleroderma, DiffuseDiffuse Cutaneous Systemic Sclerosis
Interventions
DRUG

IVA337

Capsules of 200mg IVA337

DRUG

Placebo

Identical capsules without active substance

Trial Locations (49)

10117

Charité- Universitätsmedizin Berlin, Berlin

25123

Azienda Ospedalaria Spedali Civili di Brescia, Brescia

28007

Hopital Universitario Gregorio Marañon, Madrid

28041

Hopital 12 de Octubre, Madrid

28050

Hopital Universitario Sanchinarro, Madrid

33076

Hôpital Pellegrin, Bordeaux

35128

University of Padova, Padua

37134

Universita degli Studi de Verona, Verona

46017

Hospital Universitario Dr Peset, Valencia

48149

Kilinik für Hautkrankenheiten, Münster

50139

Azienda Ospedaliera Universitaria Careggi, Florence

50931

Klinik fur Dermatologie und Venerologie der Universitat zu Köln, Cologne

59037

CHRU de Lille- Hôpital Claude Huriez, Lille

60020

Istituto di Clinica Medica Generale Polo Didattico, Ancona

61231

Kerckhoff-Klinik, Bad Nauheim

67098

University Hospital of Strasbourg, Strasbourg

67100

Ospedale San Salvatore ASL L'Aquila, L’Aquila

75014

Hopital Cochin, Paris

79106

University Medical Center Freiburg, Freiburg im Breisgau

80131

Azienda Ospedaliera Universitaria Federico II, Napoli

89081

Universtätsklinik Ulm, Ulm

91054

University of Erlangen-Nuremberg, Erlangen

Unknown

University Multiprofile Hospital for Active Treatment - Dr. Georgi Stranski, Pleven

Multiprofile Hospital for Active Treatment Plovdiv, Plovdiv

University Multiprofile Hospital for Active Treatment -Kaspela, Plovdiv

"University Multiprofile Hospital for Active Treatment - Sveti Ivan Rilski", Sofia

Chaité-Universtätsmedezin Berlin, Berlin

CIRI GmbH Centrum für Innovative Diagnostik und Therapie, Frankfurt

Leiden University Medical Center, Leiden

Erasmus MC Universitair Medisch Centrum Rotterdam, Rotterdam

Centrum Miriada Prywatny, Bialystok

University Hospital in Bydgoszcz, Bydgoszcz

CM Plejady, Krakow

Reumed, Lublin

Medycine Centrum Hetmanska Poznan, Poznan

Centrum Medyczne Oporow, Wroclaw

University Medical centre Ljubljana, Ljubljana

University Medical Centre Maribor, Maribor

Hospital La Paz, Madrid

Hospital La Princesa, Madrid

Hospital Universitario Ramon y Cajal, Madrid

University Hospital Lausanne, Lausanne

University Hospital Zurich, Zurich

01307

Univertaetsklinikum Carl Gustav Carus, Dresden

00152

"Ospedale di Alta Specializzazione San Camillo", Roma

00161

Policlinico Umberto I, Roma

08026

Hospital de la Santa Creu i Sant Pau, Barcelona

LS7 4SA

Leeds Institut of Rheumatic and Musculoskeletal Medicine, Leeds

NW3 2QG

Royal Free Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Inventiva Pharma

INDUSTRY

NCT02503644 - Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis | Biotech Hunter | Biotech Hunter